Manhattan Scientifics, Inc. (OTCPK: MHTX)
Health Care · Biotechnology · US
$0.00
+9900.00% today · +9900.0% 1Y
Manhattan Scientifics, Inc. (OTCPK: MHTX) operates in the Biotechnology industry within the Health Care sector. The company is valued at $55.93K and employs 1 people.
Over the last twelve months the share price has gained 9900.0%, trading between 0.00 and 0.00.
Tweenvest scores Manhattan Scientifics, Inc. across four factors: quality 56/100, value 49/100. Its strongest factor is quality.
MHTX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $55.93K
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.00
- Dividend yield
- —
- Beta (5Y)
- 22.32
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 559.28M
- Employees
- 1
- Next earnings
- —
About Manhattan Scientifics, Inc.
Manhattan Scientifics, Inc. operates as an innovation hub, primarily dedicated to the advancement and market introduction of technologies designed to enhance human life across the United States. The company's specialized efforts are concentrated within the fields of nanotechnology and nanomedicine. Established in 1992 and headquartered in New York City, the firm was formerly known as Grand Enterprises, Inc.
- ISIN
- US5631221000
- Founded
- 1992
- Listed since
- Jan 6, 1998
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Innovation Pharmaceuticals Inc.OTCPK: IPIX | $105.75K | $0.00 | +100.00% |
| ProtoKinetix, IncorporatedOTCPK: PKTX | $82.33K | $0.00 | +100.00% |
| Vincerx Pharma, Inc.OTCPK: VINC | $78.51K | $0.02 | -41.63% |
| MabCure, Inc.OTCPK: MBCI | $78.11K | $0.00 | -80.00% |
| Windtree Therapeutics, Inc.OTCPK: WINT | $44.99K | $0.00 | +233.33% |
| Plandaí Biotechnology, Inc.OTCPK: PLPL | $44.89K | $0.00 | -99.00% |
| Emergent Health CorpOTCPK: EMGE | $42.70K | $0.00 | — |
| Nascent Biotech, Inc.OTCPK: NBIO | $34.57K | $0.00 | +100.00% |
Figures last refreshed Oct 18, 2026.